(Total Views: 307)
Posted On: 07/02/2020 6:38:48 AM
Post# of 36541
Dr Lalezari is direct. A statement he made in an interview about Leronlimab treating CV-19:
“We are still waiting for the results of randomized, placebo-controlled studies. In the meantime, the FDA has been distracted by the foolishness around hydroxychloroquine and Remdesivir.
I believe the former is more harmful than helpful, and the latter is at best marginally helpful and only if started very early. I believe the time and energy those two drugs have taken up has prevented the FDA from seeing or understanding what’s happening with Leronlimab. “
Sounds kind of like Joe discussing some of the current vaccine platforms vs NGIO's "complete vaccine".
(0)
(0)
Scroll down for more posts ▼